Portfolio company
PolaSight
Switzerland
Raised
Undisclosed
Latest stage
Seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
PolaSight develops a polarimetric imaging device for real-time tissue assessment for pathologists to accelerate intraoperative workflows during cancer surgery.
SourceFunding history · 1
Similar companies
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
CardioSight
CardioSight develops an intravascular optical visualization and interventional delivery platform for surgeons to perform minimally invasive heart repairs without open-heart surgery.
Flash Pathology
Flash Pathology develops laser-based scanners that provide instant tissue imaging for clinicians and researchers without the need for traditional staining or preparation.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
Marginum
This company manufactures fluorescence-based tissue monitoring devices for surgeons to identify cancerous cells in surgical suction waste during oncological procedures.
Nearwave
Nearwave develops handheld, non-invasive near-infrared imaging devices to help oncologists and clinical researchers monitor breast cancer treatment efficacy and assess deep tissue biomarkers.
SamanTree Medical
This company develops digital microscopy scanners for surgeons and pathologists to perform real-time assessment of fresh tissue samples during cancer surgery.
Imeros
Imeros develops an automated multisensory apparatus using touch and ultrasound sensors to identify hard inclusions in excised tumour tissue for pathologists and surgeons.
